Login / Signup

Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis.

Joseph AzuriAriel HammermanEnis AboalhasanBen SluckisRonen Arbel
Published in: Diabetes, obesity & metabolism (2022)
Tirzepatide provides better value for money than semaglutide for weight reduction.
Keyphrases
  • weight loss
  • bariatric surgery
  • roux en y gastric bypass
  • gastric bypass
  • physical activity
  • weight gain
  • type diabetes
  • obese patients
  • body weight
  • data analysis